Literature DB >> 33931316

Prognostic Value of Computed Tomography and/or 18F-Fluorodeoxyglucose Positron Emission Tomography Radiomics Features in Locally Advanced Non-small Cell Lung Cancer.

Angel Moran1, Yichuan Wang2, Brandon A Dyer3, Stephen S F Yip4, Megan E Daly1, Tokihiro Yamamoto5.   

Abstract

INTRODUCTION: We investigated whether adding computed tomography (CT) and/or 18F-fluorodeoxyglucose (18F-FDG) PET radiomics features to conventional prognostic factors (CPFs) improves prognostic value in locally advanced non-small cell lung cancer (NSCLC).
MATERIALS AND METHODS: We retrospectively identified 39 cases with stage III NSCLC who received chemoradiotherapy and underwent planning CT and staging 18F-FDG PET scans. Seven CPFs were recorded. Feature selection was performed on 48 CT and 49 PET extracted radiomics features. A penalized multivariate Cox proportional hazards model was used to generate models for overall survival based on CPFs alone, CPFs with CT features, CPFs with PET features, and CPFs with CT and PET features. Linear predictors generated and categorized into 2 risk groups for which Kaplan-Meier survival curves were calculated. A log-rank test was performed to quantify the discrimination between the groups and calculated the Harrell's C-index to quantify the discriminatory power. A likelihood ratio test was performed to determine whether adding CT and/or PET features to CPFs improved model performance.
RESULTS: All 4 models significantly discriminated between the 2 risk groups. The discriminatory power was significantly increased when CPFs were combined with PET features (C-index 0.82; likelihood ratio test P < .01) or with both CT and PET features (0.83; P < .01) compared with CPFs alone (0.68). There was no significant improvement when CPFs were combined with CT features (0.68).
CONCLUSION: Adding PET radiomics features to CPFs yielded a significant improvement in the prognostic value in locally advanced NSCLC; adding CT features did not.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Keywords:  Carcinoma; Chemoradiotherapy; Imaging; Survival analysis; Texture features

Mesh:

Substances:

Year:  2021        PMID: 33931316      PMCID: PMC8463410          DOI: 10.1016/j.cllc.2021.03.015

Source DB:  PubMed          Journal:  Clin Lung Cancer        ISSN: 1525-7304            Impact factor:   4.840


  39 in total

1.  Do clinical, histological or immunohistochemical primary tumour characteristics translate into different (18)F-FDG PET/CT volumetric and heterogeneity features in stage II/III breast cancer?

Authors:  David Groheux; Mohamed Majdoub; Florent Tixier; Catherine Cheze Le Rest; Antoine Martineau; Pascal Merlet; Marc Espié; Anne de Roquancourt; Elif Hindié; Mathieu Hatt; Dimitris Visvikis
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-07-04       Impact factor: 9.236

2.  Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group.

Authors:  C A Perez; T F Pajak; P Rubin; J R Simpson; M Mohiuddin; L W Brady; R Perez-Tamayo; M Rotman
Journal:  Cancer       Date:  1987-06-01       Impact factor: 6.860

3.  Tumour heterogeneity in non-small cell lung carcinoma assessed by CT texture analysis: a potential marker of survival.

Authors:  Balaji Ganeshan; Elleny Panayiotou; Kate Burnand; Sabina Dizdarevic; Ken Miles
Journal:  Eur Radiol       Date:  2011-11-17       Impact factor: 5.315

4.  Combined PET/CT image characteristics for radiotherapy tumor response in lung cancer.

Authors:  Manushka Vaidya; Kimberly M Creach; Jennifer Frye; Farrokh Dehdashti; Jeffrey D Bradley; Issam El Naqa
Journal:  Radiother Oncol       Date:  2011-11-16       Impact factor: 6.280

Review 5.  Quantifying tumour heterogeneity in 18F-FDG PET/CT imaging by texture analysis.

Authors:  Sugama Chicklore; Vicky Goh; Musib Siddique; Arunabha Roy; Paul K Marsden; Gary J R Cook
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-10-13       Impact factor: 9.236

Review 6.  Applications and limitations of radiomics.

Authors:  Stephen S F Yip; Hugo J W L Aerts
Journal:  Phys Med Biol       Date:  2016-06-08       Impact factor: 3.609

7.  Optimum scanning protocol for FDG-PET evaluation of pulmonary malignancy.

Authors:  V J Lowe; D M DeLong; J M Hoffman; R E Coleman
Journal:  J Nucl Med       Date:  1995-05       Impact factor: 10.057

8.  Prognostic value and reproducibility of pretreatment CT texture features in stage III non-small cell lung cancer.

Authors:  David V Fried; Susan L Tucker; Shouhao Zhou; Zhongxing Liao; Osama Mawlawi; Geoffrey Ibbott; Laurence E Court
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-09-11       Impact factor: 7.038

9.  Comparison of texture features derived from static and respiratory-gated PET images in non-small cell lung cancer.

Authors:  Stephen Yip; Keisha McCall; Michalis Aristophanous; Aileen B Chen; Hugo J W L Aerts; Ross Berbeco
Journal:  PLoS One       Date:  2014-12-17       Impact factor: 3.240

10.  Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach.

Authors:  Hugo J W L Aerts; Emmanuel Rios Velazquez; Ralph T H Leijenaar; Chintan Parmar; Patrick Grossmann; Sara Carvalho; Sara Cavalho; Johan Bussink; René Monshouwer; Benjamin Haibe-Kains; Derek Rietveld; Frank Hoebers; Michelle M Rietbergen; C René Leemans; Andre Dekker; John Quackenbush; Robert J Gillies; Philippe Lambin
Journal:  Nat Commun       Date:  2014-06-03       Impact factor: 14.919

View more
  1 in total

Review 1.  Radiomics in Oncological PET Imaging: A Systematic Review-Part 1, Supradiaphragmatic Cancers.

Authors:  David Morland; Elizabeth Katherine Anna Triumbari; Luca Boldrini; Roberto Gatta; Daniele Pizzuto; Salvatore Annunziata
Journal:  Diagnostics (Basel)       Date:  2022-05-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.